Teriparatide 560MCG/2.24ML pen 2.24ML
Ended Awarded Last action
- Contract number
- SPE2DR26F5F6W
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,695
Award facts
- Contract value 100% obligated
- $18,695.18 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $18,695.18 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 12, 2026, for the supply of Teriparatide 560mcg/2.24ml pen injections. The contract, with an ultimate completion date of January 13, 2026, represents a single-delivery transaction executed through AmerisourceBergen's existing Indefinite Delivery Contract with the DLA Troop Support Medical. This award carries no set-aside designation, indicating the contract was competitively awarded. The place of performance is located at the contractor's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc., which serves as the parent organization in the federal pharmaceutical supply chain.
This delivery order falls under AmerisourceBergen's parent company's $999,999,999 Indefinite Delivery Contract with DLA Troop Support Medical, which extends through December 31, 2031, and serves as a comprehensive vehicle for supplying pharmaceutical products and medical supplies to support military healthcare programs globally. Teriparatide, a bone metabolism agent typically used in osteoporosis treatment, represents one of the specialized pharmaceutical commodities the contractor supplies through this contract vehicle. The firm fixed-price structure and brief performance timeline reflect standard procurement practices for routine pharmaceutical replenishment orders within the federal medical supply chain supporting Department of Defense healthcare operations.
Quick answers
Who was awarded contract SPE2DR26F5F6W?
SPE2DR26F5F6W was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26F5F6W worth?
The government has obligated $18,695 on SPE2DR26F5F6W.
Is contract SPE2DR26F5F6W an order under another contract?
Yes. SPE2DR26F5F6W is a delivery order under SPE2DR25D3306, an indefinite delivery contract.
Was contract SPE2DR26F5F6W competed?
The extent of competition for SPE2DR26F5F6W was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award